COVID-19 in Adults: Test Menu for Hospital Blood Science Laboratories

Overview

Journal Ir J Med Sci

Specialty General Medicine

Date 2020 May 20

PMID 32424603

Citations 6

Authors

Paula M OShea

Graham Robert Lee

Tomas P Griffin

Vincent Tormey

Amjad Hayat

Sean J Costelloe

Damian Gerard Griffin

Saradha Srinivasan

Maurice OKane

Conor M Burke

John Faul

Christopher J Thompson

Gerard Curley

William P Tormey

Affiliations

Soon will be listed here.

Abstract

Introduction: Coronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease.

Objective: To provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection.

Methods: Description of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection.

Results: We provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital.

Conclusion: Given the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.

Citing Articles

Two Years into the COVID-19 Pandemic: Lessons Learned.

da Silva S, do Nascimento J, Mendes R, Guarines K, Targino Alves da Silva C, Silva P ACS Infect Dis. 2022; 8(9):1758-1814.

PMID: 35940589 PMC: 9380879. DOI: 10.1021/acsinfecdis.2c00204.

Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19.

Rasmi Y, Babaei G, Nisar M, Noreen H, Gholizadeh-Ghaleh Aziz S Comp Clin Path. 2021; 30(6):1005-1021.

PMID: 34539310 PMC: 8432959. DOI: 10.1007/s00580-021-03269-2.

Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.

Safiabadi Tali S, LeBlanc J, Sadiq Z, Oyewunmi O, Camargo C, Nikpour B Clin Microbiol Rev. 2021; 34(3).

PMID: 33980687 PMC: 8142517. DOI: 10.1128/CMR.00228-20.

Survey of laboratory medicine's national response to the Covid-19 pandemic in the Republic of Ireland.

Leonard A, Murray B, Prior A, Srinivasan R, Kane A, Boran G Ir J Med Sci. 2021; 191(1):65-69.

PMID: 33665780 PMC: 7932685. DOI: 10.1007/s11845-021-02578-3.

Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.

Atila C, Sailer C, Bassetti S, Tschudin-Sutter S, Bingisser R, Siegemund M Eur J Endocrinol. 2021; 184(3):409-418.

PMID: 33449918 PMC: 9494345. DOI: 10.1530/EJE-20-1374.

References

Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J, Turner A . Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020; 126(10):1456-1474. PMC: 7188049. DOI: 10.1161/CIRCRESAHA.120.317015. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Bonow R, Fonarow G, OGara P, Yancy C . Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 2020; 5(7):751-753. DOI: 10.1001/jamacardio.2020.1105. View

Ruan Q, Yang K, Wang W, Jiang L, Song J . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846-848. PMC: 7080116. DOI: 10.1007/s00134-020-05991-x. View

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L . Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97(5):829-838. PMC: 7110296. DOI: 10.1016/j.kint.2020.03.005. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

McCartney D, Byrne D . Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19. Ir Med J. 2020; 113(4):58. View

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F . Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7):802-810. PMC: 7097841. DOI: 10.1001/jamacardio.2020.0950. View

10.

Vankadari N, Wilce J . Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020; 9(1):601-604. PMC: 7103712. DOI: 10.1080/22221751.2020.1739565. View

11.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

12.

Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-147. PMC: 7146714. DOI: 10.1016/j.thromres.2020.04.013. View

13.

Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033-1034. PMC: 7270045. DOI: 10.1016/S0140-6736(20)30628-0. View

14.

Komolmit P, Charoensuk K, Thanapirom K, Suksawatamnuay S, Thaimai P, Chirathaworn C . Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial. PLoS One. 2017; 12(4):e0174608. PMC: 5380326. DOI: 10.1371/journal.pone.0174608. View

15.

Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S . Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020; 382(17):1653-1659. PMC: 7121452. DOI: 10.1056/NEJMsr2005760. View

16.

Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J . Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006; 36(2):361-70. DOI: 10.1002/eji.200425995. View

17.

Inciardi R, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D . Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):819-824. PMC: 7364333. DOI: 10.1001/jamacardio.2020.1096. View

18.

Kwong J, Schwartz K, Campitelli M, Chung H, Crowcroft N, Karnauchow T . Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018; 378(4):345-353. DOI: 10.1056/NEJMoa1702090. View

19.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

20.

Lippi G, Plebani M . Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020; 58(7):1131-1134. DOI: 10.1515/cclm-2020-0198. View